Infection and glomerulonephritis

被引:0
作者
Saraladevi Naicker
June Fabian
Sagren Naidoo
Shoyab Wadee
Graham Paget
Stewart Goetsch
机构
[1] University of the Witwatersrand,Division of Nephrology
来源
Seminars in Immunopathology | 2007年 / 29卷
关键词
Infections; Glomerulonephritis; Human immunodeficiency virus; Streptococcal; Hepatitis B virus; Hepatitis C virus;
D O I
暂无
中图分类号
学科分类号
摘要
Glomerular injury, occurring either as primary glomerular disease or as part of a systemic disease process, is usually a result of immune-mediated mechanisms. The morphologic reaction pattern has a diverse spectrum of appearance, ranging from normal by light microscopy in minimal change disease to crescentic forms of glomerulonephritis, with conspicuous disruption of the normal glomerular morphology. The mechanisms of glomerular immune deposit formation include trapping of circulating antigen–antibody complexes and the in situ formation of immune complexes within the glomerulus. While the majority of postinfectious immune-complex-mediated glomerulonephritides are believed to result from the deposition of circulating antigen–antibody complexes, preformed outside of the kidney and secondarily deposited in the kidney, the notion of forming in situ antigen–antibody complexes to either planted antigens or to integral structural components of the glomerulus, through “cross-reacting” autoimmune reactions, is gaining popularity in a variety of forms of glomerulonephritides. Patients with HIV infection may develop a spectrum of renal pathology, the glomerular manifestations of which include both antigen–antibody complex and nonimmune-complex-mediated pathogenetic mechanisms. Similarly, patients with Streptococcal infections, Hepatitis B virus, or Hepatitis C virus infection may develop a spectrum of glomerulonephritides, which are predominantly immune-complex-mediated. Therapy for glomerular diseases due to HIV, hepatitis B, or C virus infections remains a challenge.
引用
收藏
页码:397 / 414
页数:17
相关论文
共 208 条
  • [1] Krogstad P(2003)Molecular biology of the human immunodeficiency virus: current and future targets for intervention Semin Pediatr Infect Dis 14 258-268
  • [2] Apetrei C(2004)The evolution of HIV and its consequences Infect Dis Clin N Am 18 369-394
  • [3] Marx PA(2001)Human immunodeficiency virus infection and renal failure Infect Dis Clin N Am 15 833-850
  • [4] Smith SM(2000)The nephropathies of HIV infection: pathogenesis and treatment Curr Opin Nephrol Hypertens 9 117-122
  • [5] Sreepada Rao TK(2002)Virus-related glomerular diseases: histological and clinical aspects J Nephrol 15 469-479
  • [6] Kimmel P(2003)The HIV-associated renal diseases: current insight into pathogenesis and treatment Kidney Int 63 1618-1631
  • [7] Di Belgiojoso GB(1988)HIV-associated nephropathy: a unique combined glomerular, tubular and interstitial lesion Mod Pathol 1 87-97
  • [8] Ferrario F(2001)Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy J Am Soc Nephrol 12 2645-2651
  • [9] Landriani N(2006)Viral nephropathy Nat Clin Prac Nephrol 2 254-262
  • [10] Weiner NJ(1992)Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes Proc Natl Acad Sci U S A 89 1577-1581